Efficacy of Everolimus with Reduced Cyclosporine in Japanese De Novo Renal Transplant Recipients: 24-Month, Randomized, Multicenter Study.

被引：0
|
作者：
Saito, K. [1 ]
Uchida, K. [2 ]
Takahara, S. [3 ]
Yoshimura, N. [4 ]
Teraoka, S. [5 ]
Cornu-Artis, C. [6 ]
Kobayashi, E. [7 ]
Takahashi, K. [1 ]
机构：
[1] Niigata Univ, Niigata, Japan
[2] Aichi Med Univ, Aichi, Japan
[3] Osaka Univ, Osaka, Japan
[4] Kyoto Prefectural Univ Med, Kyoto, Japan
[5] Int Univ Hlth & Welf, Atami Hosp, Shizuoka, Japan
[6] Novartis Pharma AG, Basel, Switzerland
[7] Jichi Med Univ, Shimotsuke, Tochigi, Japan
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：314 / 314
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of concentration-controlled everolimus with reduced-dose cyclosporine in Japanese de novo renal transplant patients: 12-month results
    Takahashi, Kota
    Uchida, Kazuharu
    Yoshimura, Norio
    Takahara, Shiro
    Teraoka, Satoshi
    Teshima, Rie
    Cornu-Artis, Catherine
    Kobayashi, Eiji
    TRANSPLANTATION RESEARCH, 2013, 2
  • [32] Everolimus and reduced-exposure cyclosporine in de novo renal-transplant recipients: A three-year phase II, randomized, multicenter, open-label study
    Nashan, B
    Curtis, J
    Ponticelli, C
    Mourad, G
    Jaffe, J
    Haas, T
    TRANSPLANTATION, 2004, 78 (09) : 1332 - 1340
  • [33] Everolimus-Facilitated Reduction Of Tacrolimus Provides Comparable Efficacy And Superior Renal Function Versus Standard Tacrolimus In De Novo Liver Transplant Recipients: 24-Month Results Of A Randomized Trial
    Saliba, Faouzi
    De Simone, Paolo
    Nevens, Frederik
    De Carlis, Luciano
    Metselaar, Herold
    Beckebaum, Susanne
    Jonas, Sven
    Sudan, Debra
    Fischer, Lutz
    Fung, John J.
    Dong, Gaohong
    Lopez, Patricia M.
    Junge, Guido
    HEPATOLOGY, 2012, 56 (06) : 1519 - 1519
  • [34] Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation
    Chapman, William C.
    Brown, Robert S.
    Chavin, Kenneth D.
    Sudan, Debra
    Koneru, Baburao
    Junge, Guido
    Dong, Gaohong
    Patel, Dharmesh
    Teperman, Lewis
    Fung, John J.
    TRANSPLANTATION, 2017, 101 (02) : 341 - 349
  • [35] 24 month safety results of a randomized, multicenter, double-blind study of everolimus vs azathioprine in de novo heart transplant recipients.
    Eisen, H
    Kobashigawa, J
    Starling, RC
    Cretin, N
    Jaffe, J
    Murphy, J
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 282 - 283
  • [36] Renal Function Stability in Renal Transplant Recipients Receiving Concentration-Controlled Everolimus with Reduced Cyclosporine Exposure: 24 Month Results from the A2309 Study.
    Cibrik, D.
    Kim, Y. S.
    Johnston, T.
    Walker, R.
    Zibari, G. B.
    Cornu-Artis, C.
    Vergara, M.
    Witte, S.
    Tedesco-Silva, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 406 - 407
  • [37] Economic evaluation of everolimus with reduced-dose cyclosporine in de novo renal transplant recipients: An international perspective
    Ethgen, O
    Keown, P
    Yang, X
    Ricci, JF
    Spaepen, E
    Annemans, L
    VALUE IN HEALTH, 2005, 8 (03) : 414 - 414
  • [38] Everolimus with reduced-exposure cyclosporine versus MMF and standard-exposure cyclosporine in de novo cardiac transplant recipients: 12-month results from a multicenter, Randomized trial
    Arizon, Jose
    Lehmkuhl, Hans
    Livi, Ugolino
    Vigano, Mario
    Branzi, Angelo
    Almenar, Luis
    Gerosa, Gino
    Musumeci, Francesco
    Vamous, Shaida
    Maccherini, Massimo
    Hexham, Mark
    Mange, Kevin C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 211 - 211
  • [39] Rationale and Design of a 24-Month, Prospective, International Study Assessing the Efficacy, Safety and Tolerability of Everolimus with Reduced Exposure to Cyclosporine or Tacrolimus in Pediatric Liver Transplant Recipients.
    Ganschow, R.
    Fischer, L.
    Torre, G.
    Langer, R. M.
    Ericzon, B. G.
    Brunati, A.
    Sips, C.
    Balfour, A.
    Junge, G.
    LIVER TRANSPLANTATION, 2013, 19 : S176 - S176
  • [40] Everolimus with reduced-exposure cyclosporine in de novo heart transplant patients: 6-month results of a multicenter, randomized trial.
    Zuckermann, A.
    Wang, S. S.
    Keogh, A.
    Ross, H.
    Frigerio, M.
    Eisen, H.
    Bara, C.
    Laufer, G.
    Cotrufo, M.
    Lena, S.
    Sips, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 443 - 443
12345